Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bethesda, Maryland
- Most recent report
- 10-Q, filed Aug 14, 2026
- Incorporated
- Delaware
- Filings on record
- 802 filings
- On EDGAR
- CIK 1072379
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 126
News 8 of 246
- 8-K Significant contract Jul 31, 2026
- 8-K Current report on a material event Jul 20, 2026
- 8-K Acquisition or disposal closed Apr 7, 2026
- 8-K Other events Jan 15, 2026
- 8-K Shareholder vote results Jan 2, 2026
- 8-K Significant contract Nov 20, 2025
- 8-K Significant contract Oct 31, 2025
- 8-K Significant contract Oct 30, 2025
Prospectuses and Registrations 8 of 93
- 424B5 Prospectus supplement for an offering Jul 31, 2026
- POS AM Post-effective amendment to a registration Apr 16, 2026
- 424B5 Prospectus supplement for an offering Nov 25, 2025
- S-3 Shelf registration statement Oct 24, 2025
- 424B5 Prospectus supplement for an offering Jul 1, 2025
- 424B5 Prospectus supplement for an offering Dec 26, 2024
- S-3 Shelf registration statement Oct 18, 2022
- 424B5 Prospectus supplement for an offering Oct 13, 2020
Proxies 8 of 29
- DEF 14A Proxy statement for a shareholder vote Nov 28, 2025
- PRE 14A Preliminary proxy statement Nov 19, 2025
- DEFA14A Extra proxy material Jun 25, 2024
- DEF 14A Proxy statement for a shareholder vote Jun 3, 2024
- PRE 14A Preliminary proxy statement May 22, 2024
- DEFA14A Extra proxy material Dec 23, 2022
- DEFA14A Extra proxy material Dec 16, 2022
- DEF 14A Proxy statement for a shareholder vote Dec 5, 2022
Ownership 8 of 166
- 4 Insider reported a trade Sep 3, 2024
- 4 Insider reported a trade Aug 13, 2024
- 4 Insider reported a trade Aug 8, 2024
- 4 Insider reported a trade Jul 30, 2024
- 4 Insider reported a trade Dec 1, 2023
- 4 Insider reported a trade Apr 5, 2023
- 4 Insider reported a trade Apr 5, 2023
- 5 Insider reported deferred transactions Feb 7, 2023
Other 8 of 142
- EFFECT Notice that a registration became effective Apr 20, 2026
- NT 10-K Notice that an annual report will be late Mar 31, 2026
- EFFECT Notice that a registration became effective Nov 25, 2025
- CORRESP Reply to SEC staff Nov 24, 2025
- NT 10-K Notice that an annual report will be late Mar 1, 2024
- EFFECT Notice that a registration became effective Oct 25, 2022
- CORRESP Reply to SEC staff Oct 24, 2022
- UPLOAD Comment letter from SEC staff Oct 21, 2022
Everything here comes from Northwest Biotherapeutics Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.